TradingView
RocketTickers
26 de Ago de 2019 22:02

Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal S Viés de alta

NASDAQ:AKRX1D

Descrição

⋅
AKRX: Akorn, Inc.
2019-08-26 13:35:36
Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.15%
Beyond Technical Analysis
Mais